ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17

• Main Authors: Junting Zhang (Author), Yiying Li (Author), Jianchao Zhang (Author), Lu Liu (Author), Yuan Chen (Author), Xusheng Yang (Author), Xueyi Liao (Author), Muhua He (Author), Zihui Jia (Author), Jun Fan (Author), Jin-Song Bian (Author), Xiaowei Nie (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pulmonary hypertension (PH) is an extremely malignant pulmonary vascular disease of unknown etiology. ADAR1 is an RNA editing enzyme that converts adenosine in RNA to inosine, thereby affecting RNA expression. However, the role of ADAR1 in PH development remains unclear. In the present study, we inv...